Influenza viruses with mutant PB2 gene segment as live attenuated vaccines
US9101653B2 · kind B2 · utility
17Cited by
11References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 24, 2012 |
| Grant date | Aug 11, 2015 |
| Priority date | — |
| Expiry date | Oct 12, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/11
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a recombinant biologically contained influenza virus that is a PB2 knockout virus, e.g., one that is useful to generate a multivalent vaccine, and methods of making and using that virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.